Can a patient on chronic dialysis receive antihypertensive medication during the dialysis session?

Can Dialysis Patients Receive Blood Pressure Medication During Dialysis?

Yes, dialysis patients can and often should receive antihypertensive medications during dialysis, with timing individualized based on intradialytic blood pressure patterns rather than routinely withholding medications before sessions.

Key Recommendation

The 2020 KDIGO guidelines explicitly state that the timing of antihypertensive medication administration should be individualized, taking into account interdialytic BP and the frequency of intradialytic hypotension 1. The effectiveness of routinely withholding antihypertensive agents before dialysis to reduce intradialytic hypotension remains unproven 1.

Evidence-Based Approach

When to Continue Medications During Dialysis

• Most patients should take their BP medications as prescribed, including on dialysis days
• A 2021 cluster randomized trial found that taking BP medications before hemodialysis (versus holding them) reduced uncontrolled hypertension by 15% without definitively increasing intradialytic hypotension 2
• Current practice of withholding medications is based on little evidence, yet more than half of dialysis patients employ this method despite lack of supporting data 3

Medication Selection Considerations

First-line agents include ACE inhibitors/ARBs and calcium channel blockers, similar to the general population 1. However, dialyzability matters:

• Long-acting, once-daily medications (e.g., lisinopril, amlodipine) can be administered directly during dialysis sessions by staff, ensuring compliance 4, 5
• Nondialyzable beta-blockers (propranolol) may provide better intradialytic arrhythmia protection compared to dialyzable ones (atenolol, metoprolol) 1
• However, nondialyzable agents like carvedilol may increase intradialytic hypotension risk 1

Timing Strategy Based on BP Patterns

For patients with stable intradialytic BP:

• Use once-daily, longer-acting medications to improve adherence
• Administer at night to control nocturnal hypertension and minimize intradialytic hypotension 6

For patients with frequent intradialytic hypotension:

• Consider avoiding nondialyzable medications 1
• Prioritize non-pharmacologic interventions first (volume control, UF rate adjustment, target weight reassessment)
• May consider holding morning doses on dialysis days, though evidence is limited 1

Special Populations: Non-Compliant Patients

For patients who don't reliably take medications at home, a proven strategy involves unit-administered long-acting agents on dialysis days 4:

• Lisinopril (long half-life in renal failure)
• Amlodipine (intrinsically long-acting)
• Transdermal clonidine (weekly patch)

This approach achieved significant BP reductions (systolic -15 mmHg, diastolic -12 mmHg) with excellent patient acceptance 4.

Critical Pitfalls to Avoid

• Don't routinely withhold all BP medications before dialysis - this practice lacks evidence and may worsen hypertension control 3, 2
• Don't use short-acting agents requiring thrice-daily dosing - high pill burden leads to non-compliance and rebound hypertension 6
• Don't ignore volume status - most BP elevation in dialysis stems from volume overload; address this before escalating medications 1

Clinical Algorithm

1. Assess volume status first - optimize dry weight and sodium removal
2. If BP remains elevated after volume optimization - initiate or uptitrate antihypertensives
3. Choose medications based on:
   • Intradialytic BP pattern (stable vs. frequent hypotension)
   • Dialyzability (avoid nondialyzable if frequent IDH)
   • Cardiovascular indications
   • Patient adherence likelihood
4. Default to continuing medications on dialysis days unless specific contraindications exist
5. Consider unit-administered dosing for non-adherent patients

The evidence strongly supports moving away from routine medication withholding and toward individualized strategies that prioritize BP control while monitoring for intradialytic complications 1, 2.